glp 1 ras mechanism GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes Frontiers | GLP−1 receptor agonists
Description
Thyroid Cancer Risk : There has been concern about a potential link between GLP-1 receptor agonists and the development of thyroid cancer
Still in trials: Orforglipron is not yet FDA-approved
Do not dismiss it
It makes the molecule more prone to aggregation, the process where peptide molecules clump together and lose their individual functionality
